Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Biomea Fusion Inc ha un obiettivo di prezzo di consenso pari a $28.83, stabilito in base alle ultime valutazioni degli analisti di 19. Le ultime 3 valutazioni degli analisti sono state rilasciate da Citigroup, Scotiabank y D. Boral Capital il agosto 11, 2025, agosto 6, 2025 y agosto 6, 2025. Con un obiettivo di prezzo medio di $11 tra le Citigroup, Scotiabank y D. Boral Capital, c'è un implicito 514.32% upside per Biomea Fusion Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Citigroup
Scotiabank
D. Boral Capital
Piper Sandler
HC Wainwright & Co.
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Biomea Fusion
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
08/11/2025 | 290.93% | Citigroup | $9 → $7 | Maintains | Buy | |||
08/06/2025 | 458.47% | Scotiabank | $30 → $10 | Maintains | Sector Outperform | |||
08/06/2025 | 793.56% | D. Boral Capital | $16 → $16 | Maintains | Buy | |||
07/21/2025 | 793.56% | D. Boral Capital | $16 → $16 | Maintains | Buy | |||
07/16/2025 | 402.62% | Citigroup | $22 → $9 | Maintains | Buy | |||
06/24/2025 | 793.56% | D. Boral Capital | $16 → $16 | Maintains | Buy | |||
06/18/2025 | 793.56% | D. Boral Capital | $16 → $16 | Maintains | Buy | |||
06/13/2025 | 793.56% | D. Boral Capital | $16 → $16 | Maintains | Buy | |||
06/03/2025 | 290.93% | Piper Sandler | → $7 | Assumes | → Overweight | |||
05/15/2025 | 793.56% | D. Boral Capital | $16 → $16 | Maintains | Buy | |||
05/06/2025 | 793.56% | D. Boral Capital | $16 → $16 | Maintains | Buy | |||
05/06/2025 | 905.25% | HC Wainwright & Co. | $40 → $18 | Maintains | Buy | |||
04/02/2025 | 67.54% | Barclays | $11 → $3 | Maintains | Equal-Weight | |||
04/01/2025 | 2133.89% | HC Wainwright & Co. | $40 → $40 | Reiterates | Buy → Buy | |||
03/31/2025 | 2133.89% | HC Wainwright & Co. | $40 → $40 | Reiterates | Buy → Buy | |||
03/25/2025 | 2133.89% | HC Wainwright & Co. | $40 → $40 | Reiterates | Buy → Buy | |||
03/24/2025 | 2133.89% | HC Wainwright & Co. | $40 → $40 | Reiterates | Buy → Buy | |||
03/24/2025 | 793.56% | D. Boral Capital | $16 → $16 | Maintains | Buy | |||
03/19/2025 | 793.56% | D. Boral Capital | $16 → $16 | Maintains | Buy | |||
01/16/2025 | 2133.89% | HC Wainwright & Co. | $40 → $40 | Reiterates | Buy → Buy | |||
01/14/2025 | 2133.89% | HC Wainwright & Co. | $40 → $40 | Reiterates | Buy → Buy | |||
01/13/2025 | 793.56% | D. Boral Capital | $128 → $16 | Maintains | Buy | |||
01/10/2025 | 7048.44% | D. Boral Capital | $128 → $128 | Maintains | Buy | |||
12/19/2024 | 7048.44% | D. Boral Capital | $128 → $128 | Maintains | Buy | |||
12/18/2024 | 2133.89% | HC Wainwright & Co. | $40 → $40 | Reiterates | Buy → Buy | |||
12/17/2024 | 7048.44% | D. Boral Capital | $128 → $128 | Maintains | Buy | |||
12/16/2024 | 2133.89% | HC Wainwright & Co. | $40 → $40 | Reiterates | Buy → Buy | |||
12/10/2024 | 7048.44% | D. Boral Capital | $128 → $128 | Maintains | Buy | |||
12/10/2024 | 2133.89% | HC Wainwright & Co. | $40 → $40 | Reiterates | Buy → Buy | |||
11/21/2024 | 2133.89% | HC Wainwright & Co. | $40 → $40 | Reiterates | Buy → Buy | |||
11/19/2024 | 7048.44% | D. Boral Capital | $128 → $128 | Maintains | Buy | |||
10/31/2024 | 961.1% | Piper Sandler | $10 → $19 | Maintains | Overweight | |||
10/31/2024 | 7048.44% | EF Hutton | $128 → $128 | Maintains | Buy | |||
10/31/2024 | 2133.89% | HC Wainwright & Co. | $40 → $40 | Reiterates | Buy → Buy | |||
10/30/2024 | 514.32% | Barclays | $9 → $11 | Maintains | Equal-Weight | |||
10/30/2024 | 7048.44% | EF Hutton | $128 → $128 | Maintains | Buy | |||
10/22/2024 | 2133.89% | HC Wainwright & Co. | $40 → $40 | Reiterates | Buy → Buy | |||
10/09/2024 | 7048.44% | EF Hutton | → $128 | Initiates | → Buy | |||
09/27/2024 | 2189.74% | Scotiabank | $21 → $41 | Maintains | Sector Outperform | |||
09/27/2024 | 2133.89% | HC Wainwright & Co. | $15 → $40 | Maintains | Buy | |||
09/27/2024 | 402.62% | Barclays | $5 → $9 | Maintains | Equal-Weight | |||
09/27/2024 | 2915.75% | Truist Securities | $54 → $54 | Upgrade | Hold → Buy | |||
09/26/2024 | 905.25% | Rodman & Renshaw | → $18 | Upgrade | Neutral → Buy | |||
08/29/2024 | 1296.18% | Capital One | → $25 | Initiates | → Overweight | |||
08/27/2024 | 1128.64% | Citigroup | $45 → $22 | Maintains | Buy | |||
08/01/2024 | 737.71% | HC Wainwright & Co. | $15 → $15 | Reiterates | Buy → Buy | |||
06/25/2024 | 737.71% | HC Wainwright & Co. | $15 → $15 | Reiterates | Buy → Buy | |||
06/11/2024 | — | Truist Securities | — | Downgrade | Buy → Hold | |||
06/07/2024 | 2413.12% | Citigroup | $90 → $45 | Maintains | Buy | |||
06/07/2024 | 737.71% | HC Wainwright & Co. | $50 → $15 | Maintains | Buy | |||
06/07/2024 | 458.47% | Piper Sandler | $45 → $10 | Maintains | Overweight | |||
06/07/2024 | 179.24% | Barclays | $30 → $5 | Downgrade | Overweight → Equal-Weight | |||
06/07/2024 | 1072.79% | Scotiabank | $41 → $21 | Maintains | Sector Outperform | |||
05/30/2024 | 3250.83% | Oppenheimer | $70 → $60 | Maintains | Outperform | |||
05/03/2024 | 2692.36% | HC Wainwright & Co. | $50 → $50 | Reiterates | Buy → Buy | |||
05/03/2024 | 737.71% | JP Morgan | $14 → $15 | Maintains | Neutral | |||
04/03/2024 | 3809.3% | Oppenheimer | → $70 | Maintains | Outperform | |||
04/02/2024 | 681.86% | JP Morgan | $51 → $14 | Downgrade | Overweight → Neutral | |||
04/01/2024 | 2692.36% | HC Wainwright & Co. | $50 → $50 | Reiterates | Buy → Buy | |||
04/01/2024 | 2971.6% | Truist Securities | → $55 | Reiterates | Buy → Buy | |||
03/06/2024 | 2692.36% | HC Wainwright & Co. | $50 → $50 | Reiterates | Buy → Buy | |||
02/06/2024 | 2971.6% | Truist Securities | → $55 | Initiates | → Buy | |||
12/08/2023 | 4926.25% | Citigroup | → $90 | Reiterates | Buy → Buy | |||
08/01/2023 | 2301.43% | EF Hutton | → $43 | Reiterates | Buy → Buy | |||
08/01/2023 | 2692.36% | HC Wainwright & Co. | → $50 | Reiterates | Buy → Buy | |||
07/27/2023 | 2189.74% | Scotiabank | → $41 | Initiates | → Sector Outperform | |||
07/25/2023 | 2301.43% | EF Hutton | → $43 | Reiterates | Buy → Buy | |||
07/24/2023 | 2692.36% | HC Wainwright & Co. | $50 → $50 | Reiterates | Buy → Buy | |||
07/12/2023 | 2301.43% | EF Hutton | → $43 | Reiterates | Buy → Buy | |||
06/26/2023 | 1463.72% | Jefferies | $36 → $28 | Downgrade | Buy → Hold | |||
06/26/2023 | 2413.12% | Piper Sandler | $40 → $45 | Maintains | Overweight | |||
06/26/2023 | 2748.21% | JP Morgan | $38 → $51 | Maintains | Overweight | |||
06/26/2023 | 4926.25% | Citigroup | $53 → $90 | Maintains | Buy | |||
06/26/2023 | 1687.11% | EF Hutton | → $32 | Reiterates | Buy → Buy | |||
06/26/2023 | 2692.36% | HC Wainwright & Co. | $37 → $50 | Maintains | Buy | |||
05/25/2023 | 1687.11% | EF Hutton | → $32 | Assumes | → Buy | |||
05/18/2023 | 2859.9% | Citigroup | $55 → $53 | Maintains | Buy | |||
05/12/2023 | 2692.36% | Barclays | → $50 | Initiates | → Overweight | |||
05/04/2023 | 1687.11% | EF Hutton | $33 → $32 | Reiterates | → Buy | |||
05/03/2023 | 1966.35% | HC Wainwright & Co. | → $37 | Reiterates | → Buy | |||
04/19/2023 | 1966.35% | HC Wainwright & Co. | $44 → $37 | Maintains | Buy | |||
04/11/2023 | 2524.82% | Oppenheimer | → $47 | Reiterates | → Outperform | |||
04/07/2023 | 2971.6% | Citigroup | $60 → $55 | Maintains | Buy | |||
04/06/2023 | 1742.96% | EF Hutton | → $33 | Reiterates | → Buy | |||
03/29/2023 | 2524.82% | Oppenheimer | $25 → $47 | Maintains | Outperform | |||
03/29/2023 | 3250.83% | Citigroup | $20 → $60 | Maintains | Buy | |||
03/29/2023 | 2357.28% | HC Wainwright & Co. | → $44 | Reiterates | → Buy | |||
03/28/2023 | 2357.28% | HC Wainwright & Co. | $37 → $44 | Reiterates | → Buy | |||
03/28/2023 | 1742.96% | EF Hutton | $22 → $33 | Maintains | Buy | |||
03/28/2023 | 2133.89% | Piper Sandler | $16 → $40 | Maintains | Overweight | |||
03/24/2023 | 1128.64% | Keefe, Bruyette & Woods | → $22 | Reiterates | → Buy | |||
03/22/2023 | 1128.64% | EF Hutton | → $22 | Reiterates | → Buy | |||
03/21/2023 | 1128.64% | EF Hutton | → $22 | Reiterates | → Buy | |||
02/24/2023 | 1016.94% | Citigroup | → $20 | Initiates | → Buy | |||
01/13/2023 | 1966.35% | HC Wainwright & Co. | → $37 | Reiterates | → Buy | |||
11/08/2022 | 1128.64% | EF Hutton | $27 → $22 | Maintains | Buy | |||
11/01/2022 | 1407.87% | EF Hutton | → $27 | Initiates | → Buy | |||
10/31/2022 | 1966.35% | HC Wainwright & Co. | $16 → $37 | Maintains | Buy |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Biomea Fusion (BMEA)?
El último precio objetivo de Biomea Fusion (NASDAQ:BMEA) fue comunicado por Citigroup el agosto 11, 2025. La firma de analistas fijó un precio objetivo para $7.00 que espera BMEA a rise dentro de 12 meses (un posible 290.93% upside). 45 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Biomea Fusion (BMEA)?
La última calificación de analistas para Biomea Fusion (NASDAQ:BMEA) fue proporcionada por Citigroup, y Biomea Fusion mantuvo su buy calificación.
¿Cuándo se produjo la última revisión al alza de Biomea Fusion (BMEA)?
La última revisión al alza de Biomea Fusion Inc se produjo en septiembre 27, 2024, cuando Truist Securities elevó su precio objetivo a $54. Truist Securities anteriormente tenía a hold para Biomea Fusion Inc.
¿Cuándo fue la última revisión a la baja de Biomea Fusion (BMEA)?
La última revisión a la baja de Biomea Fusion Inc se produjo en junio 11, 2024, cuando Truist Securities cambió su precio objetivo de N/A a N/A para Biomea Fusion Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Biomea Fusion (BMEA)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Biomea Fusion, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Biomea Fusion se registró el agosto 11, 2025, por lo que la próxima calificación estará disponible en torno al agosto 11, 2026.
¿Es correcta la calificación de los analistas sobre Biomea Fusion (BMEA)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Biomea Fusion (BMEA) fue un mantuvo con un precio objetivo de $9.00 a $7.00. El precio actual al que cotiza Biomea Fusion (BMEA) es de $1.79, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.